SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001356576-23-000053
Filing Date
2023-08-10
Accepted
2023-08-10 17:15:24
Documents
14
Period of Report
2023-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A supn-20230808.htm   iXBRL 8-K/A 40581
2 EX-99.1 ex99108-08x2023corrected.htm EX-99.1 221860
6 supernuslogo.jpg GRAPHIC 19991
  Complete submission text file 0001356576-23-000053.txt   436387

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20230808.xsd EX-101.SCH 1917
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT supn-20230808_lab.xml EX-101.LAB 24138
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20230808_pre.xml EX-101.PRE 12522
8 EXTRACTED XBRL INSTANCE DOCUMENT supn-20230808_htm.xml XML 2729
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-35518 | Film No.: 231160665
SIC: 2834 Pharmaceutical Preparations